GSK Leaving Pennsylvania Emergen-C Plant, Adding Voltaren To US OTC Line
Executive Summary
UK pharma announced that in 2021 it will close its manufacturing facility in Carlisle, PA, where around 260 people are employed making the Emergen-C line. It will move the manufacturing to its Guayama, PR, facility.